NanoViricides Inc

General ticker "NNVC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $19.7M

NanoViricides Inc follows the US Stock Market performance with the rate: 15.4%.

Estimated limits based on current volatility of 2.9%: low 1.45$, high 1.54$

Factors to consider:

  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [1.55$, 3.27$]
  • 2025-06-30 to 2026-06-30 estimated range: [1.40$, 2.98$]

Financial Metrics affecting the NNVC estimates:

  • Negative: Non-GAAP EPS, $ of -0.70 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -18.61 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -22.98 <= 1.31
  • Negative: Industry operating profit margin (median), % of -100 <= 2.14
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term NNVC quotes

Long-term NNVC plot with estimates

Financial data

YTD 2022-06-30 2023-06-30 2024-06-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $8.11MM $8.94MM $8.52MM
Operating Income $-8.11MM $-8.94MM $-8.52MM
Non-Operating Income $0.01MM $0.35MM $0.22MM
Interest Expense $0.01MM $0.00MM $0.00MM
R&D Expense $5.78MM $6.39MM $5.44MM
Income(Loss) $-8.11MM $-8.59MM $-8.29MM
Profit(Loss) $-8.11MM $-8.59MM $-8.29MM
Stockholders Equity $23.08MM $14.87MM $11.46MM
Assets $23.49MM $16.90MM $12.82MM
Operating Cash Flow $-5.89MM $-5.67MM $-6.32MM
Capital expenditure $0.32MM $0.15MM $0.16MM
Investing Cash Flow $-0.32MM $-0.15MM $-0.16MM
Financing Cash Flow $-0.23MM $-0.09MM $3.12MM
Earnings Per Share* $-0.70 $-0.74 $-0.70

* EPS are Split Adjusted, recent splits may be reflected with a delay.